Response of the pulmonary circulation to acetylcholine, calcitonin gene-related peptide, substance P and oral nicardipine in patients with primary pulmonary hypertension
NG Uren,
PF Ludman,
T Crake,
and
CM Oakley
Department of Medicine, Hammersmith Hospital, London, England.
Endothelium-dependent vasodilation of the pulmonary vascular bed was investigated in five patients with primary pulmonary hypertension. Three endothelium-dependent vasodilators (acetylcholine, calcitonin gene-related peptide and substance P [in two patients]) were infused sequentially into the right atrium, followed by nicardipine given orally during full hemodynamic monitoring. Acetylcholine, calcitonin gene-related peptide and substance P had no effect on pulmonary artery pressure, total pulmonary vascular resistance or cardiac output, although calcitonin gene-related peptide significantly decreased systemic arterial systolic pressure from 132 +/- 34 to 113 +/- 33 mm Hg. In contrast, oral nicardipine decreased total pulmonary vascular resistance from 23 +/- 12 to 13 +/- 8 U, with a concomitant increase in cardiac output from 3.1 +/- 1 to 4.7 +/- 2 liters.min-1 and decrease in systemic vascular resistance from 30 +/- 9 to 13 +/- 4 U. Thus, despite the presence of a reversible component in these five patients with primary pulmonary hypertension, pulmonary vascular resistance did not decrease in response to the infused endothelium-dependent vasodilator agents, indicating that endothelium-dependent vasodilation is impaired in these patients.
This article has been cited by other articles:
|
|
|
|
 
S. D. Brain and A. D. Grant
Vascular Actions of Calcitonin Gene-Related Peptide and Adrenomedullin
Physiol Rev,
July 1, 2004;
84(3):
903 - 934.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Schulze-Neick, D. J. Penny, M. L. Rigby, C. Morgan, A. Kelleher, P. Collins, J. Li, A. Bush, E. A. Shinebourne, and A. N. Redington
L-Arginine and Substance P Reverse the Pulmonary Endothelial Dysfunction Caused by Congenital Heart Surgery
Circulation,
August 17, 1999;
100(7):
749 - 755.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L.-W. Chen, C.-F. Chen, and Y.-L. Lai
Chronic activation of neurokinin-1 receptor induces pulmonary hypertension in rats
Am J Physiol Heart Circ Physiol,
May 1, 1999;
276(5):
H1543 - H1551.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Meeran, D. O'Shea, P. D. Upton, C. J. Small, M. A. Ghatei, P. H. Byfield, and S. R. Bloom
Circulating Adrenomedullin Does Not Regulate Systemic Blood Pressure but Increases Plasma Prolactin after Intravenous Infusion in Humans: A Pharmacokinetic Study
J. Clin. Endocrinol. Metab.,
January 1, 1997;
82(1):
95 - 100.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Okada, C. Yamashita, M. Okada, and K. Okada
Role of Endothelin-1 in Beagles With Dehydromonocrotaline-Induced Pulmonary Hypertension
Circulation,
July 1, 1995;
92(1):
114 - 119.
[Abstract]
[Full Text]
|
|
|
|
